News stories about Cyanotech (NASDAQ:CYAN) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cyanotech earned a coverage optimism score of 0.09 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 44.9748869205227 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Cyanotech (NASDAQ:CYAN) remained flat at $$3.80 during midday trading on Friday. 4,290 shares of the company’s stock were exchanged, compared to its average volume of 2,815. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.36 and a quick ratio of 0.72. The company has a market capitalization of $21.54, a price-to-earnings ratio of 63.33 and a beta of 1.06. Cyanotech has a twelve month low of $3.25 and a twelve month high of $5.35.
Cyanotech (NASDAQ:CYAN) last posted its quarterly earnings data on Monday, November 6th. The biotechnology company reported $0.08 EPS for the quarter. The company had revenue of $8.06 million for the quarter. Cyanotech had a net margin of 1.11% and a return on equity of 2.06%.
Separately, ValuEngine lowered shares of Cyanotech from a “hold” rating to a “sell” rating in a research note on Friday, November 10th.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://ledgergazette.com/2018/01/19/cyanotech-cyan-getting-somewhat-favorable-media-coverage-study-shows.html.
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.